Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026)
Regenerative Medical Technology's EBITDA Margin was 16.33% in Q2 2026, up 36.18 percentage points from -19.86% a year earlier and up 3.92 percentage points from the prior quarter.
Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenerative Medical Technology's EBITDA Margin was 4.32% through Jun 30, 2026, down 5.03 percentage points year-over-year; for FY2025, it came in at -11.49%, down 18.84 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +801.15 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 7.35% in FY2024 (+24.16 pp), -16.81% in FY2023 (+50.64 pp), -67.45% in FY2022 (+2188.54 pp) and -2255.99% in FY2021 (-1443.35 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q4 2024.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +0.84 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2022 (a gain of 5421.47 percentage points); the worst was Q3 2021 (a drop of 5060.16 percentage points).
- Per Business Quant data, RMTG's EBITDA Margin in the three quarters before Q2 2026 was 12.41% (Q1 2026), -13.23% (Q4 2025) and -31.31% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Regenerative Medical Technology | 549,558.71 | -3.98 Mn | 2.58 Mn | 24.91% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.91% |
| Mar 31, 2026 | 40.06% |
| Dec 31, 2025 | 37.03% |
| Sep 30, 2025 | 12.60% |
| Jun 30, 2025 | -19.86% |
| Mar 31, 2025 | 13.69% |
| Dec 31, 2024 | 23.64% |
| Sep 30, 2024 | 17.70% |
| Jun 30, 2024 | 113.50% |
| Mar 31, 2024 | 121.93% |
| Dec 31, 2023 | 117.94% |
| Sep 30, 2023 | 121.87% |
| Jun 30, 2023 | 108.53% |
| Mar 31, 2023 | 95.19% |
| Dec 31, 2022 | 65.86% |
| Sep 30, 2022 | 85.23% |
| Jun 30, 2022 | 36.50% |
| Mar 31, 2022 | -23.53% |
| Dec 31, 2021 | -29.86% |
| Sep 30, 2021 | -5,284.68% |
Regenerative Medical Technology EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();